Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-121683·Ernexa Therapeutics Inc.
Schedule 13G ownership disclosure
ERNEXA THERAPEUTICS INC
Common Stock, par value $0.005 per share · CUSIP: 114082308
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shameek Konar
Shares: 558,531.00 · Class: 7.12%
- Victoria Konar
Shares: 558,531.00 · Class: 7.12%
- Regolith Capital Investments LP
Shares: 547,668.00 · Class: 6.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-121683
- Form type
- SCHEDULE 13G/A
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- Dec 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership